Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ · Manufacturing · Pharmaceutical preparations
$5.17$0.00 (0.00%) on the dayAs of the close; data may be delayed.
AVIR price, last 12 months
Key stats
- Previous close
- $5.17
- Open
- $5.16
- Day range
- $5.04 – $5.21
- 52-week range
- $2.78 – $6.45
- Volume
- 280.7K
- Avg volume (20 days)
- 287.4K
- Market cap
- $414.7M
Performance
1W−3.0%
1M−6.2%
3M+15.1%
6M−3.0%
YTD+44.8%
1Y+78.3%
vs S&P 500, 1Y+61.5 pts
Technicals and fundamentals
About Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $414.7M